SBC Medical Group (NASDAQ:SBC) Reaches New 52-Week High – Still a Buy?

SBC Medical Group Holdings Incorporated (NASDAQ:SBC)’s stock price reached a new 52-week high during trading on Thursday. The stock traded as high as $5.61 and last traded at $5.6040, with a volume of 61,660 shares. The stock had previously closed at $5.54.

Analysts Set New Price Targets

SBC has been the topic of several research reports. BTIG Research restated a “buy” rating and issued a $8.00 target price on shares of SBC Medical Group in a research report on Thursday, August 13th. Weiss Ratings raised shares of SBC Medical Group from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, October 9th. Finally, Wall Street Zen upgraded SBC Medical Group from a “buy” rating to a “strong-buy” rating in a research report on Monday, October 5th. Two equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $8.50.

SBC Medical Group Stock Up 2.7%

The stock has a market capitalization of $585.22 million, a price-to-earnings ratio of 12.11, a PEG ratio of 2.45 and a beta of 0.56. The company has a debt-to-equity ratio of 0.09, a current ratio of 3.31 and a quick ratio of 3.27. The business has a fifty day moving average of $4.62 and a 200 day moving average of $3.75.

SBC Medical Group (NASDAQ:SBC) last posted its earnings results on Thursday, August 13th. The company reported $0.10 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.12 by ($0.02). SBC Medical Group had a return on equity of 18.47% and a net margin of 27.99%. The business had revenue of $49.19 million for the quarter, compared to analyst estimates of $45.37 million. As a group, equities analysts predict that SBC Medical Group Holdings Incorporated will post 0.44 earnings per share for the current year.

Institutional Trading of SBC Medical Group

Hedge funds and other institutional investors have recently modified their holdings of the business. BlackRock Inc. acquired a new position in SBC Medical Group in the second quarter valued at about $2,846,000. Citadel Advisors LLC acquired a new stake in shares of SBC Medical Group during the second quarter valued at about $446,000. Segall Bryant & Hamill LLC acquired a new stake in shares of SBC Medical Group during the first quarter valued at about $340,000. Bank of New York Mellon Corp acquired a new stake in shares of SBC Medical Group during the second quarter valued at about $83,000. Finally, Central Pacific Bank Trust Division purchased a new stake in shares of SBC Medical Group in the 2nd quarter valued at approximately $74,000. 60.82% of the stock is owned by institutional investors and hedge funds.

SBC Medical Group Company Profile

SBC Medical Group Holdings Incorporated (NASDAQ: SBC) is a healthcare company focused on supporting medical institutions, particularly clinics that provide aesthetic and cosmetic medical treatments. Its business includes management services, operational support and products designed to help medical providers deliver care and manage their practices.

The company is associated with the Shonan Beauty Clinic network, which offers services such as cosmetic surgery, dermatology, hair restoration and other aesthetic procedures.